TrialClinical and translational science2022

A phase I study to evaluate the safety, tolerability, pharmacodynamic and pharmacokinetic profiles of ocular GLH8NDE in healthy male adults.

Jihyun Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.